Skip to main content

Favorite Annette F's Form 4 filing

West Pharmaceutical Services Inc (WST) · filed Sep 1, 2023

Accession no.
0001562180-23-006659
Filed
Sep 1, 2023
Trade date
Aug 30, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $829.3K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Favorite Annette FCIK 0001654975Officer (Sr. VP & Chief HR Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 30, 2023Common StockMOption exerciseAcquired+2,000$83.47+$166,94016,876.96Direct
Aug 30, 2023Common StockSSaleDisposed−760$414.20−$314,79216,116.96Direct
Aug 30, 2023Common StockSSaleDisposed−1,240$414.91−$514,488.414,876.96Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 30, 2023Common StockMOption exerciseDisposed−2,000$0.00$08,452Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)